APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gemcitabine Hydrochloride API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gemcitabine Hydrochloride API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173276240327 December 2025196 pages

Choose your research edition.

Industry ResearchGemcitabine Hydrochloride API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gemcitabine Hydrochloride API Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gemcitabine Hydrochloride API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gemcitabine Hydrochloride API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gemcitabine Hydrochloride API Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gemcitabine Hydrochloride API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gemcitabine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gemcitabine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gemcitabine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gemcitabine Hydrochloride API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gemcitabine Hydrochloride API include Zhejiang Hisun Pharmaceutical, Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical, Shanghai Chuangnuo Pharmaceutical, Shandong Anhong Pharmaceutical, Fu'an Pharmaceutical Group, Hubei Bantian Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group, Jiangsu Zhengda Qingjiang Pharmaceutical and Lianyungang Jerry Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Gemcitabine Hydrochloride API output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Gemcitabine Hydrochloride API by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Gemcitabine Hydrochloride API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gemcitabine Hydrochloride API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gemcitabine Hydrochloride API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gemcitabine Hydrochloride API market size, projected growth trends, production technologies, key applications, and end-use industries.

Gemcitabine Hydrochloride API Segment by Company

Zhejiang Hisun Pharmaceutical

Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical

Shanghai Chuangnuo Pharmaceutical

Shandong Anhong Pharmaceutical

Fu'an Pharmaceutical Group

Hubei Bantian Pharmaceutical

Jiangsu Hansoh Pharmaceutical Group

Jiangsu Zhengda Qingjiang Pharmaceutical

Lianyungang Jerry Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Lianyungang Runzhong Pharmaceutical

Sanofi

Gemcitabine Hydrochloride API Segment by Type

0.98

0.99

Others

Gemcitabine Hydrochloride API Segment by Application

Pharmaceutical

Research

Gemcitabine Hydrochloride API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine Hydrochloride API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gemcitabine Hydrochloride API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gemcitabine Hydrochloride API industry.

Chapter 3: Detailed analysis of Gemcitabine Hydrochloride API market competition landscape. Including Gemcitabine Hydrochloride API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Gemcitabine Hydrochloride API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Gemcitabine Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Gemcitabine Hydrochloride API Industry Trends Table 2. Gemcitabine Hydrochloride API Industry Drivers Table 3. Gemcitabine Hydrochloride API Industry Opportunities and Challenges Table 4. Gemcitabine Hydrochloride API Industry Restraints Table 5. Global Gemcitabine Hydrochloride API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gemcitabine Hydrochloride API Production Value Share by Manufacturers (2021-2026) Table 7. Global Gemcitabine Hydrochloride API Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Gemcitabine Hydrochloride API Production Market Share by Manufacturers Table 9. Global Gemcitabine Hydrochloride API Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Gemcitabine Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gemcitabine Hydrochloride API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gemcitabine Hydrochloride API Manufacturers, Product Type & Application Table 13. Global Gemcitabine Hydrochloride API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gemcitabine Hydrochloride API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of 0.98 Table 17. Major Manufacturers of 0.99 Table 18. Major Manufacturers of Others Table 19. Global Gemcitabine Hydrochloride API Production by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Gemcitabine Hydrochloride API Production by Type (2021-2026) & (Tons) Table 21. Global Gemcitabine Hydrochloride API Production by Type (2027-2032) & (Tons) Table 22. Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2026) Table 23. Global Gemcitabine Hydrochloride API Production Market Share by Type (2027-2032) Table 24. Global Gemcitabine Hydrochloride API Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Gemcitabine Hydrochloride API Production Value by Type (2021-2026) & (Tons) Table 26. Global Gemcitabine Hydrochloride API Production Value by Type (2027-2032) & (Tons) Table 27. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2021-2026) Table 28. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceutical Table 30. Major Manufacturers of Research Table 31. Global Gemcitabine Hydrochloride API Production by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Gemcitabine Hydrochloride API Production by Application (2021-2026) & (Tons) Table 33. Global Gemcitabine Hydrochloride API Production by Application (2027-2032) & (Tons) Table 34. Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2026) Table 35. Global Gemcitabine Hydrochloride API Production Market Share by Application (2027-2032) Table 36. Global Gemcitabine Hydrochloride API Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Gemcitabine Hydrochloride API Production Value by Application (2021-2026) & (Tons) Table 38. Global Gemcitabine Hydrochloride API Production Value by Application (2027-2032) & (Tons) Table 39. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2021-2026) Table 40. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2027-2032) Table 41. Zhejiang Hisun Pharmaceutical Company Information Table 42. Zhejiang Hisun Pharmaceutical Business Overview Table 43. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 44. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 45. Zhejiang Hisun Pharmaceutical Recent Development Table 46. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Company Information Table 47. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Business Overview Table 48. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 49. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 50. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Development Table 51. Shanghai Chuangnuo Pharmaceutical Company Information Table 52. Shanghai Chuangnuo Pharmaceutical Business Overview Table 53. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 54. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 55. Shanghai Chuangnuo Pharmaceutical Recent Development Table 56. Shandong Anhong Pharmaceutical Company Information Table 57. Shandong Anhong Pharmaceutical Business Overview Table 58. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 60. Shandong Anhong Pharmaceutical Recent Development Table 61. Fu'an Pharmaceutical Group Company Information Table 62. Fu'an Pharmaceutical Group Business Overview Table 63. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 65. Fu'an Pharmaceutical Group Recent Development Table 66. Hubei Bantian Pharmaceutical Company Information Table 67. Hubei Bantian Pharmaceutical Business Overview Table 68. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 70. Hubei Bantian Pharmaceutical Recent Development Table 71. Jiangsu Hansoh Pharmaceutical Group Company Information Table 72. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 73. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 75. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 76. Jiangsu Zhengda Qingjiang Pharmaceutical Company Information Table 77. Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview Table 78. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 80. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development Table 81. Lianyungang Jerry Pharmaceutical Company Information Table 82. Lianyungang Jerry Pharmaceutical Business Overview Table 83. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 85. Lianyungang Jerry Pharmaceutical Recent Development Table 86. Shandong Luoxin Pharmaceutical Group Company Information Table 87. Shandong Luoxin Pharmaceutical Group Business Overview Table 88. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 90. Shandong Luoxin Pharmaceutical Group Recent Development Table 91. Lianyungang Runzhong Pharmaceutical Company Information Table 92. Lianyungang Runzhong Pharmaceutical Business Overview Table 93. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 95. Lianyungang Runzhong Pharmaceutical Recent Development Table 96. Sanofi Company Information Table 97. Sanofi Business Overview Table 98. Sanofi Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Sanofi Gemcitabine Hydrochloride API Product Portfolio Table 100. Sanofi Recent Development Table 101. Global Gemcitabine Hydrochloride API Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 102. Global Gemcitabine Hydrochloride API Production by Region (2021-2026) & (Tons) Table 103. Global Gemcitabine Hydrochloride API Production Market Share by Region (2021-2026) Table 104. Global Gemcitabine Hydrochloride API Production Forecast by Region (2027-2032) & (Tons) Table 105. Global Gemcitabine Hydrochloride API Production Market Share Forecast by Region (2027-2032) Table 106. Global Gemcitabine Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 107. Global Gemcitabine Hydrochloride API Production Value by Region (2021-2026) & (US$ Million) Table 108. Global Gemcitabine Hydrochloride API Production Value Share by Region (2021-2026) Table 109. Global Gemcitabine Hydrochloride API Production Value by Region (2027-2032) & (US$ Million) Table 110. Global Gemcitabine Hydrochloride API Production Value Share by Region: (2027-2032) & (US$ Million) Table 111. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2021-2026) Table 112. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2027-2032) Table 113. Global Gemcitabine Hydrochloride API Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 114. Global Gemcitabine Hydrochloride API Consumption by Region (2021-2026) & (Tons) Table 115. Global Gemcitabine Hydrochloride API Consumption Market Share by Region (2021-2026) Table 116. Global Gemcitabine Hydrochloride API Consumption Forecasted by Region (2027-2032) & (Tons) Table 117. Global Gemcitabine Hydrochloride API Consumption Forecasted Market Share by Region (2027-2032) Table 118. North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 119. North America Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 120. North America Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 121. Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 122. Europe Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 123. Europe Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 124. Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 125. Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 126. Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 127. South America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 128. South America Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 129. South America Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 130. Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 131. Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 132. Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Gemcitabine Hydrochloride API Distributors List Table 136. Gemcitabine Hydrochloride API Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Gemcitabine Hydrochloride API Product Image Figure 2. Global Gemcitabine Hydrochloride API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 4. Global Gemcitabine Hydrochloride API Production Capacity (2021-2032) & (Tons) Figure 5. Global Gemcitabine Hydrochloride API Production (2021-2032) & (Tons) Figure 6. Global Gemcitabine Hydrochloride API Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Gemcitabine Hydrochloride API Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.98 Image Figure 10. 0.99 Image Figure 11. Others Image Figure 12. Global Gemcitabine Hydrochloride API Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Gemcitabine Hydrochloride API Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2032) Figure 15. Global Gemcitabine Hydrochloride API Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Gemcitabine Hydrochloride API Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gemcitabine Hydrochloride API Production Value Share by Type (2021-2032) Figure 18. Pharmaceutical Image Figure 19. Research Image Figure 20. Global Gemcitabine Hydrochloride API Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Gemcitabine Hydrochloride API Production Market Share 2021 VS 2025 VS 2032 Figure 22. Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2032) Figure 23. Global Gemcitabine Hydrochloride API Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Gemcitabine Hydrochloride API Production Value Share 2021 VS 2025 VS 2032 Figure 25. Global Gemcitabine Hydrochloride API Production Value Share by Application (2021-2032) Figure 26. Global Gemcitabine Hydrochloride API Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Gemcitabine Hydrochloride API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Gemcitabine Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Gemcitabine Hydrochloride API Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 31. Europe Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 33. South America Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 35. North America Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. North America Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 37. U.S. Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. Canada Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Mexico Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Europe Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Europe Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 42. Germany Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. France Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. U.K. Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Italy Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Netherlands Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Asia Pacific Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 49. China Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Japan Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. South Korea Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Southeast Asia Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. India Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Australia Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. South America Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 57. Brazil Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. Argentina Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Chile Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Middle East & Africa Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Middle East & Africa Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 62. Egypt Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. South Africa Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. Israel Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Türkiye Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. GCC Countries Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. Gemcitabine Hydrochloride API Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Gemcitabine Hydrochloride API Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.98
  • 0.99
  • Others
Applications
  • Pharmaceutical
  • Research
Companies covered
  • Zhejiang Hisun Pharmaceutical
  • Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical
  • Shanghai Chuangnuo Pharmaceutical
  • Shandong Anhong Pharmaceutical
  • Fu'an Pharmaceutical Group
  • Hubei Bantian Pharmaceutical
  • Jiangsu Hansoh Pharmaceutical Group
  • Jiangsu Zhengda Qingjiang Pharmaceutical
  • Lianyungang Jerry Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Lianyungang Runzhong Pharmaceutical
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gemcitabine Hydrochloride API Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Gemcitabine Hydrochloride API Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Gemcitabine Hydrochloride API Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Gemcitabine Hydrochloride API Market Dynamics
  1. 2.1 Gemcitabine Hydrochloride API Industry Trends
  2. 2.2 Gemcitabine Hydrochloride API Industry Drivers
  3. 2.3 Gemcitabine Hydrochloride API Industry Opportunities and Challenges
  4. 2.4 Gemcitabine Hydrochloride API Industry Restraints
3 Gemcitabine Hydrochloride API Market by Manufacturers
  1. 3.1 Global Gemcitabine Hydrochloride API Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Gemcitabine Hydrochloride API Production by Manufacturers (2021-2026)
  3. 3.3 Global Gemcitabine Hydrochloride API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Gemcitabine Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gemcitabine Hydrochloride API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gemcitabine Hydrochloride API Manufacturers, Product Type & Application
  7. 3.7 Global Gemcitabine Hydrochloride API Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gemcitabine Hydrochloride API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gemcitabine Hydrochloride API Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Gemcitabine Hydrochloride API Tier 1, Tier 2, and Tier 3
4 Gemcitabine Hydrochloride API Market by Type
  1. 4.1 Gemcitabine Hydrochloride API Type Introduction
  2. 4.1.1 0.98
  3. 4.1.2 0.99
  4. 4.1.3 Others
  5. 4.2 Global Gemcitabine Hydrochloride API Production by Type
  6. 4.2.1 Global Gemcitabine Hydrochloride API Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gemcitabine Hydrochloride API Production by Type (2021-2032)
  8. 4.2.3 Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2032)
  9. 4.3 Global Gemcitabine Hydrochloride API Production Value by Type
  10. 4.3.1 Global Gemcitabine Hydrochloride API Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gemcitabine Hydrochloride API Production Value by Type (2021-2032)
  12. 4.3.3 Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2021-2032)
5 Gemcitabine Hydrochloride API Market by Application
  1. 5.1 Gemcitabine Hydrochloride API Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Research
  4. 5.2 Global Gemcitabine Hydrochloride API Production by Application
  5. 5.2.1 Global Gemcitabine Hydrochloride API Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gemcitabine Hydrochloride API Production by Application (2021-2032)
  7. 5.2.3 Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2032)
  8. 5.3 Global Gemcitabine Hydrochloride API Production Value by Application
  9. 5.3.1 Global Gemcitabine Hydrochloride API Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gemcitabine Hydrochloride API Production Value by Application (2021-2032)
  11. 5.3.3 Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Zhejiang Hisun Pharmaceutical
  2. 6.1.1 Zhejiang Hisun Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Hisun Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  6. 6.1.5 Zhejiang Hisun Pharmaceutical Recent Developments
  7. 6.2 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical
  8. 6.2.1 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Company Information
  9. 6.2.2 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Business Overview
  10. 6.2.3 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  12. 6.2.5 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Developments
  13. 6.3 Shanghai Chuangnuo Pharmaceutical
  14. 6.3.1 Shanghai Chuangnuo Pharmaceutical Company Information
  15. 6.3.2 Shanghai Chuangnuo Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  18. 6.3.5 Shanghai Chuangnuo Pharmaceutical Recent Developments
  19. 6.4 Shandong Anhong Pharmaceutical
  20. 6.4.1 Shandong Anhong Pharmaceutical Company Information
  21. 6.4.2 Shandong Anhong Pharmaceutical Business Overview
  22. 6.4.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  24. 6.4.5 Shandong Anhong Pharmaceutical Recent Developments
  25. 6.5 Fu'an Pharmaceutical Group
  26. 6.5.1 Fu'an Pharmaceutical Group Company Information
  27. 6.5.2 Fu'an Pharmaceutical Group Business Overview
  28. 6.5.3 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio
  30. 6.5.5 Fu'an Pharmaceutical Group Recent Developments
  31. 6.6 Hubei Bantian Pharmaceutical
  32. 6.6.1 Hubei Bantian Pharmaceutical Company Information
  33. 6.6.2 Hubei Bantian Pharmaceutical Business Overview
  34. 6.6.3 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  36. 6.6.5 Hubei Bantian Pharmaceutical Recent Developments
  37. 6.7 Jiangsu Hansoh Pharmaceutical Group
  38. 6.7.1 Jiangsu Hansoh Pharmaceutical Group Company Information
  39. 6.7.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
  40. 6.7.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio
  42. 6.7.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  43. 6.8 Jiangsu Zhengda Qingjiang Pharmaceutical
  44. 6.8.1 Jiangsu Zhengda Qingjiang Pharmaceutical Company Information
  45. 6.8.2 Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview
  46. 6.8.3 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  48. 6.8.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Developments
  49. 6.9 Lianyungang Jerry Pharmaceutical
  50. 6.9.1 Lianyungang Jerry Pharmaceutical Company Information
  51. 6.9.2 Lianyungang Jerry Pharmaceutical Business Overview
  52. 6.9.3 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  54. 6.9.5 Lianyungang Jerry Pharmaceutical Recent Developments
  55. 6.10 Shandong Luoxin Pharmaceutical Group
  56. 6.10.1 Shandong Luoxin Pharmaceutical Group Company Information
  57. 6.10.2 Shandong Luoxin Pharmaceutical Group Business Overview
  58. 6.10.3 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio
  60. 6.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  61. 6.11 Lianyungang Runzhong Pharmaceutical
  62. 6.11.1 Lianyungang Runzhong Pharmaceutical Company Information
  63. 6.11.2 Lianyungang Runzhong Pharmaceutical Business Overview
  64. 6.11.3 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio
  66. 6.11.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Gemcitabine Hydrochloride API Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Gemcitabine Hydrochloride API Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
7 Global Gemcitabine Hydrochloride API Production by Region
  1. 7.1 Global Gemcitabine Hydrochloride API Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Gemcitabine Hydrochloride API Production by Region (2021-2032)
  3. 7.2.1 Global Gemcitabine Hydrochloride API Production by Region (2021-2026)
  4. 7.2.2 Global Gemcitabine Hydrochloride API Production Forecast by Region (2027-2032)
  5. 7.3 Global Gemcitabine Hydrochloride API Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Gemcitabine Hydrochloride API Production Value by Region (2021-2032)
  7. 7.4.1 Global Gemcitabine Hydrochloride API Production Value by Region (2021-2026)
  8. 7.4.2 Global Gemcitabine Hydrochloride API Production Value by Region (2027-2032)
  9. 7.5 Global Gemcitabine Hydrochloride API Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Gemcitabine Hydrochloride API Production Value (2021-2032)
  12. 7.6.2 Europe Gemcitabine Hydrochloride API Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Gemcitabine Hydrochloride API Production Value (2021-2032)
  14. 7.6.4 South America Gemcitabine Hydrochloride API Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Gemcitabine Hydrochloride API Production Value (2021-2032)
8 Global Gemcitabine Hydrochloride API Consumption by Region
  1. 8.1 Global Gemcitabine Hydrochloride API Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Gemcitabine Hydrochloride API Consumption by Region (2021-2032)
  3. 8.2.1 Global Gemcitabine Hydrochloride API Consumption by Region (2021-2026)
  4. 8.2.2 Global Gemcitabine Hydrochloride API Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gemcitabine Hydrochloride API Value Chain Analysis
  2. 9.1.1 Gemcitabine Hydrochloride API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gemcitabine Hydrochloride API Production Mode & Process
  6. 9.2 Gemcitabine Hydrochloride API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gemcitabine Hydrochloride API Distributors
  9. 9.2.3 Gemcitabine Hydrochloride API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst